APT-1011

· Ellodi Pharmaceuticals, LP

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for APT-1011, covering 2023-04-26 to 2025-08-13. Get the full timeline:

Most recent: Clinical Trial Update: 24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3) [Phase 3]